Pathstone Holdings’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.33M | Sell |
15,181
-284
| -2% | -$24.8K | 0.01% | 1240 |
|
2025
Q1 | $1.06M | Buy |
15,465
+197
| +1% | +$13.5K | ﹤0.01% | 1352 |
|
2024
Q4 | $1.19M | Sell |
15,268
-2,335
| -13% | -$182K | 0.01% | 1273 |
|
2024
Q3 | $1.18M | Sell |
17,603
-10,237
| -37% | -$686K | 0.01% | 1273 |
|
2024
Q2 | $3.16M | Buy |
27,840
+1,734
| +7% | +$197K | 0.01% | 708 |
|
2024
Q1 | $3.62M | Buy |
26,106
+217
| +0.8% | +$30.1K | 0.02% | 637 |
|
2023
Q4 | $3.21M | Buy |
+25,889
| New | +$3.21M | 0.02% | 560 |
|